| European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease JF Rahier, S Ben-Horin, Y Chowers, C Conlon, P De Munter, G D'Haens, ... Journal of Crohn's and Colitis 3 (2), 47-91, 2009 | 702 | 2009 |
| ECCO guidelines on the prevention, diagnosis, and management of infections in inflammatory bowel disease T Kucharzik, P Ellul, T Greuter, JF Rahier, B Verstockt, C Abreu, ... Journal of Crohn's and Colitis 15 (6), 879-913, 2021 | 309 | 2021 |
| European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations S Miehlke, D Guagnozzi, Y Zabana, GE Tontini, AM Kanstrup Fiehn, ... UEG Journal 9 (1), 13-37, 2021 | 189 | 2021 |
| Sexual function and patients' perceptions in inflammatory bowel disease: a case–control survey L Marín, M Mañosa, E Garcia-Planella, J Gordillo, Y Zabana, E Cabré, ... Journal of gastroenterology 48, 713-720, 2013 | 136 | 2013 |
| Fecundity, pregnancy outcomes, and breastfeeding in patients with inflammatory bowel disease: a large cohort survey M Mañosa, M Navarro-Llavat, L Marín, Y Zabana, E Cabré, E Domènech Scandinavian journal of gastroenterology 48 (4), 427-432, 2013 | 107 | 2013 |
| Steroid-refractory ulcerative colitis: predictive factors of response to cyclosporine and validation in an independent cohort M Aceituno, E García-Planella, C Heredia, Y Zabana, F Feu, E Domènech, ... Inflammatory bowel diseases 14 (3), 347-352, 2008 | 81 | 2008 |
| Phenotype and natural history of elderly onset inflammatory bowel disease: a multicentre, case‐control study M Mañosa, M Calafat, R De Francisco, C García, MJ Casanova, P Huelín, ... Alimentary pharmacology & therapeutics 47 (5), 605-614, 2018 | 77 | 2018 |
| Infliximab safety profile and long‐term applicability in inflammatory bowel disease: 9‐year experience in clinical practice Y Zabana, E Domenech, M Mañosa, E Garcia‐Planella, I Bernal, E Cabré, ... Alimentary pharmacology & therapeutics 31 (5), 553-560, 2010 | 74 | 2010 |
| Effectiveness and safety of ustekinumab in ulcerative colitis: Real-world evidence from the ENEIDA registry M Chaparro, A Garre, M Iborra, M Sierra-Ausín, M Barreiro-de Acosta, ... Journal of Crohn's and Colitis 15 (11), 1846-1851, 2021 | 65 | 2021 |
| Relevant infections in inflammatory bowel disease, and their relationship with immunosuppressive therapy and their effects on disease mortality Y Zabana, L Rodríguez, T Lobatón, J Gordillo, A Montserrat, R Mena, ... Journal of Crohn's and Colitis 13 (7), 828-837, 2019 | 57 | 2019 |
| Long-term outcome of ulcerative colitis in patients who achieve clinical remission with a first course of corticosteroids E Garcia-Planella, M Mañosa, M Van Domselaar, J Gordillo, Y Zabana, ... Digestive and Liver Disease 44 (3), 206-210, 2012 | 57 | 2012 |
| Tuberculous chemoprophylaxis requirements and safety in inflammatory bowel disease patients prior to anti-TNF therapy Y Zabana, E Domènech, AL San Román, B Beltrán, JL Cabriada, C Saro, ... Inflammatory bowel diseases 14 (10), 1387-1391, 2008 | 57 | 2008 |
| Impact of surveillance of hepatitis b and hepatitis c in patients with inflammatory bowel disease under anti-TNF therapies: multicenter prospective observational study … C Loras, JP Gisbert, MC Saro, M Piqueras, C Sánchez-Montes, J Barrio, ... Journal of Crohn's and Colitis 8 (11), 1529-1538, 2014 | 53 | 2014 |
| Systemic amyloidosis in inflammatory bowel disease: retrospective study on its prevalence, clinical presentation, and outcome I Serra, B Oller, M Mañosa, JE Naves, Y Zabana, E Cabré, E Domènech Journal of Crohn's and Colitis 4 (3), 269-274, 2010 | 53 | 2010 |
| Increased risk of thiopurine‐related adverse events in elderly patients with IBD M Calafat, M Mañosa, F Cañete, E Ricart, E Iglesias, M Calvo, ... Alimentary pharmacology & therapeutics 50 (7), 780-788, 2019 | 52 | 2019 |
| Long-term methotrexate for Crohn's disease: safety and efficacy in clinical practice E Domènech, M Mañosa, M Navarro, H Masnou, E Garcia-Planella, ... Journal of clinical gastroenterology 42 (4), 395-399, 2008 | 47 | 2008 |
| Fecal calprotectin levels are closely correlated with the absence of relevant mucosal lesions in postoperative Crohn's disease E Garcia-Planella, M Mañosa, E Cabré, L Marín, J Gordillo, Y Zabana, ... Inflammatory bowel diseases 22 (12), 2879-2885, 2016 | 45 | 2016 |
| Decision tree for early introduction of rescue therapy in active ulcerative colitis treated with steroids M Mañosa, E Cabré, E Garcia-Planella, I Bernal, J Gordillo, M Esteve, ... Inflammatory bowel diseases 17 (12), 2497-2502, 2011 | 43 | 2011 |
| The ENEIDA registry (Nationwide study on genetic and environmental determinants of inflammatory bowel disease) by GETECCU: Design, monitoring and functions Y Zabana, J Panés, P Nos, F Gomollón, M Esteve, V García-Sánchez, ... Gastroenterología y Hepatología (English Edition) 43 (9), 551-558, 2020 | 40 | 2020 |
| Clinical outcome of newly diagnosed Crohn’s disease: a comparative, retrospective study before and after infliximab availability E Domenech, Y Zabana, E Garcia‐Planella, A López San Román, P Nos, ... Alimentary pharmacology & therapeutics 31 (2), 233-239, 2010 | 40 | 2010 |
